Autologous peripheral blood stem cell transplantation in a patient with previous invasive middle ear mucormycosis

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1183-1184

  Olalla, I ^a   Ortin M ^a   Hermida, G ^a   Cortes M A ^a   Richard, C ^a   Iriondo, A ^a   Mozota, M L ^a   Zubizarreta, A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Acute myeloid leukemia; Autologous peripheral blood stem cell transplantation; Invasive middle ear mucormycosis

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BACTERIAL INFECTION; CASE REPORT; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; MUCORMYCOSIS; NEUTROPENIA; OTITIS MEDIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRUS INFECTION;

ACUTE DISEASE; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYTARABINE; FACIAL PARALYSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; LEUKEMIA, MYELOID; MALE; MASTOID; MIDDLE AGED; MITOXANTRONE; MUCORMYCOSIS; MYRINGOPLASTY; NEUTROPENIA; OTITIS MEDIA, SUPPURATIVE; REMISSION INDUCTION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030476556     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marchevsky AM. Bottone EJ, Geller SA, Giger DK. The changing spectrum of the disease, etiology and diagnosis of mucormycosis. Hum Pathol 1980; 11: 457-64.
2. Rinaldi M. Zygomycocis. Infect Dis Clin North Am 1989; 3: 19-41.
3. Meunier F. Fungal infections in the immunocompromised host. In: Rubin RH, Young LS (eds). Clinical Approach to Infection in the Compromised Host. Plenum: New York, 1989, pp 193-220.
4. Morrison VA, McGlave PB. Mucormycosis in the BMT population. Bone Marrow Transplant 1993; 11: 383-388.
5. Nollaig A, Parfrey MB. Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine 1986; 65: 113-123.
6. Garcia-Martos P, Delgado D, Marín P, Mira J. Analisis de 40 casos de otomicosis. Enf Infec Microbiol Clin (Barc) 1993; 11: 487-489.
7. Schattenberg A, De Vries F, De Witte T, Cohen O, Donnelly JP, De Pauw BE. Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung. Bone Marrow Transplant 1988; 3: 509-512.
8. Lupinetti FM, Behrendt DM, Giller RH, Trigg ME, Alarcon P. Pulmonary resection for fungal infection in children undergoing bone marrow transplantation. J Thorac Cardiov Surg 1992; 104: 684-687.
9. Karp JE, Burch PA, Merz WG. An approach to intensive anti-leukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988; 85: 203-206.
10. Richard C, Romón I, Baro J et al. Invasive pulmonary aspergillosis prior to BMT does not predict a poor outcome. Bone Marrow Transplant 1993; 12: 237-241.
11. Martine R, Nomdedéu J, Altés A et al. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. Bone Marrow Transplant 1994; 13: 265-269.
12. Bjerke JW, Meyers JD, Bowden RA. Hepatosplenic candidiasis: contraindication to marrow transplantation? Blood 1994; 84: 2811-2814.
13. Walsh TJ. Management of immunocompromised patients with evidence of an invasive mycosis. Hematol Oncol Clin North Am 1993; 7: 1003-1026.
14. Nemunaitis J, Meyers JD, Buckner CD et al. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 1991; 78: 907-913.
15. Bodey GP, Anaissie E, Gutterman J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Infect Dis 1993; 17: 705-707.